A

Asian Phytoceuticals PCL
SET:APCO

Watchlist Manager
Asian Phytoceuticals PCL
SET:APCO
Watchlist
Price: 5.25 THB Market Closed
Market Cap: 3.2B THB
Have any thoughts about
Asian Phytoceuticals PCL?
Write Note

Balance Sheet

Balance Sheet Decomposition
Asian Phytoceuticals PCL

Current Assets 316.4m
Cash & Short-Term Investments 262.5m
Receivables 4.5m
Other Current Assets 49.4m
Non-Current Assets 298.6m
Long-Term Investments 204.6m
PP&E 74.7m
Intangibles 693.9k
Other Non-Current Assets 18.6m
Current Liabilities 41.7m
Accounts Payable 1.6m
Accrued Liabilities 15.5m
Other Current Liabilities 24.6m
Non-Current Liabilities 45.5m
Long-Term Debt 17.6m
Other Non-Current Liabilities 28m

Balance Sheet
Asian Phytoceuticals PCL

Rotate your device to view
Balance Sheet
Currency: THB
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
377
214
222
244
182
160
100
99
82
126
Cash
153
133
222
244
182
160
100
99
82
126
Cash Equivalents
224
81
0
0
0
0
0
0
0
0
Short-Term Investments
0
195
315
271
313
320
72
68
97
126
Total Receivables
15
12
4
4
5
1
5
3
4
4
Accounts Receivables
13
5
4
4
5
1
4
3
4
4
Other Receivables
2
7
0
0
0
0
1
0
0
0
Inventory
52
48
51
53
67
62
62
60
53
44
Other Current Assets
2
4
2
2
2
1
2
1
2
1
Total Current Assets
447
473
596
574
569
545
241
231
238
301
PP&E Net
106
147
107
94
84
71
113
91
64
82
PP&E Gross
106
147
107
94
84
71
113
91
64
82
Accumulated Depreciation
69
84
78
88
100
114
125
125
131
138
Intangible Assets
1
1
1
1
1
1
1
0
0
1
Long-Term Investments
1
1
0
2
3
4
332
347
365
304
Other Long-Term Assets
8
7
8
8
9
10
10
11
13
17
Total Assets
563
N/A
629
+12%
711
+13%
679
-5%
666
-2%
630
-5%
697
+11%
681
-2%
680
0%
705
+4%
Liabilities
Accounts Payable
1
2
2
2
2
1
1
2
1
1
Accrued Liabilities
21
24
23
19
18
19
16
13
14
16
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
0
0
18
19
12
13
Other Current Liabilities
18
23
26
18
17
12
14
14
18
16
Total Current Liabilities
40
49
50
38
37
31
49
48
45
46
Long-Term Debt
0
0
0
0
0
0
32
15
2
22
Minority Interest
0
0
0
0
0
0
0
0
3
3
Other Liabilities
7
12
12
13
15
19
21
22
23
24
Total Liabilities
48
N/A
61
+28%
62
+2%
50
-19%
52
+2%
51
-2%
101
+100%
86
-16%
72
-16%
95
+32%
Equity
Common Stock
272
275
300
300
300
300
300
300
300
300
Retained Earnings
160
145
182
161
147
112
125
127
146
162
Additional Paid In Capital
83
148
167
167
167
167
167
167
167
167
Unrealized Security Profit/Loss
0
0
0
0
0
0
3
1
5
19
Total Equity
515
N/A
568
+10%
649
+14%
628
-3%
614
-2%
579
-6%
595
+3%
595
0%
608
+2%
610
+0%
Total Liabilities & Equity
563
N/A
629
+12%
711
+13%
679
-5%
666
-2%
630
-5%
697
+11%
681
-2%
680
0%
705
+4%
Shares Outstanding
Common Shares Outstanding
587
593
600
600
600
600
600
600
600
600

See Also

Discover More